Difference between revisions of "Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5 (Q9614)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 94, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English) | ||
| Property / title: miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:59, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yu D, et al. Lab. Invest. (2014) cited as Ref 351 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yu D
0 references
Shin HS
0 references
Lee YS
0 references
2014
0 references
Lab. Invest.
0 references
94
0 references
miR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cells (English)
0 references
